NCT05353114

Brief Summary

Patients with diabetes at high risk of ulceration require a perfect fitting shoe to avoid high shear and pressure forces. Neuropathy skews sensory perceptions and can alter the proper selection of the therapeutic footwear. The aims of study were to evaluate the ability of high-risk patients with diabetes in remission to select the proper therapeutic footwear and to validate a novel 3D foot scanner app for selecting the proper fitting therapeutic footwear.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 29, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

June 15, 2022

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2022

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

15 days

First QC Date

April 22, 2022

Last Update Submit

November 2, 2022

Conditions

Keywords

PreventionTherapeutic footwearNew technologies

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure was the requirement of Therapeutic Footwear change after prescription because ill fitting.

    Validation of proper therapeutic footwear fitting was performed by a specialized podiatrist after acquisition of shoes in both groups. TF was recommended to change when following ill fitting reason were found: excessive length or tight, or compromise with toes

    1 week

Secondary Outcomes (1)

  • Number of participants with an ulcer occurrence event

    1 month

Study Arms (2)

Standard Therapeutic Footwear prescription group

NO INTERVENTION

1\) Patients that will acquire the therapeutic footwear size and model according to aesthetic preferences

Therapeutic Footwear prescription based on a 3D Foot scanner

EXPERIMENTAL

2\) Patients that will acquire a specific size and model according to result of a novel mobile app 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).

Other: 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).

Interventions

The 3D foot scan becomes a movile app that recommends a specific size and model of therapeutic footwear according to the measurements

Therapeutic Footwear prescription based on a 3D Foot scanner

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • High risk patients according to the International Working Group Diabetic Foot Guidelines (IWGDF-risk 3).
  • Capability to walk autonomously without walking aids.
  • Diabetic Peripheral neuropathy.

You may not qualify if:

  • Major amputation in the contralateral limb (below or above the knee).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Universitaria de Podología de la Universidad Complutense de Madrid

Madrid, 28040, Spain

Location

MeSH Terms

Conditions

Diabetic FootMusculoskeletal Diseases

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr

Study Record Dates

First Submitted

April 22, 2022

First Posted

April 29, 2022

Study Start

June 15, 2022

Primary Completion

June 30, 2022

Study Completion

July 15, 2022

Last Updated

November 4, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations